دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Kawasaki Disease: A Systematic Review and Meta-Analysis of Benefits and Harms of Common Treatments
Karen E. James,Mohamad A. Kalot,Nedaa M. Husainat,Anisha B. Dua,Kevin Byram,Jason M. Springer,Yih Chang Lin,Marat Turgunbaev,Alexandra Villa-Forte,Mark Gorelik,Andy Abril,Carol Langford,Mehrdad Maz,Sharon A. Chung,Reem A. Mustafa
doi : 10.1002/acr2.11308
Volume 3, Issue 10 p. 671-683
Kawasaki disease (KD) is a self-limited vasculitis affecting medium-sized vessels with a predilection for the coronary arteries. Although treatment reduces the likelihood of developing of coronary artery aneurysms, 5% of patients still develop aneurysms despite treatment, making KD the leading cause of acquired heart disease in children in the United States. Consequently, there is a great deal of interest in optimizing treatment regimens, particularly for higher-risk patients, to decrease morbidity. The aim of this systematic review is to support the development of the American College of Rheumatology/Vasculitis Foundation for the diagnosis and management of KD, focusing on the more complex scenarios in which rheumatologists may become involved, such as high-risk and refractory disease.
Combinations of Anticyclic Citrullinated Protein Antibody, Rheumatoid Factor, and Serum Calprotectin Positivity Are Associated With the Diagnosis of Rheumatoid Arthritis Within 3 Years
Leah F. Bettner,Ryan A. Peterson,Dylan T. Bergstedt,Lindsay B. Kelmenson,M. Kristen Demoruelle,Ted R. Mikuls,Jess D. Edison,Mark C. Parish,Marie L. Feser,Ashley A. Frazer-Abel,Laura K. Moss,Michael Mahler,V. Michael Holers,Kevin D. Deane
doi : 10.1002/acr2.11309
Volume 3, Issue 10 p. 684-689
To evaluate the prevalence of elevations of anti-cyclic citrullinated peptide-3 (anti-CCP3) antibody, rheumatoid factor IgM (RF-IgM) and serum calprotectin (sCP) in pre–rheumatoid arthritis (RA) as well as the diagnostic accuracies of these biomarkers for the timing of diagnosis of future RA.
The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology
Meera Subash,Lucy H. Liu,Kimberly DeQuattro,Sonam Choden,Lindsay Jacobsohn,Patricia Katz,Puneet Bajaj,Jennifer L. Barton,Christie Bartels,Bonnie Bermas,Maria I. Danila,Christina Downey,Sancia Ferguson,Kimberly Reiter,Elizabeth Wahl,Elena Weinstein,JoAnn Zell,Gabriela Schmajuk,Jinoos Yazdany
doi : 10.1002/acr2.11310
Volume 3, Issue 10 p. 690-698
Patient-reported outcomes (PROs) are an integral part of treat-to-target approaches in managing rheumatoid arthritis (RA). In clinical practice, however, routine collection, documentation, and discussion of PROs with patients are highly variable. The RISE LC (Rheumatology Informatics System for Effectiveness Learning Collaborative) was established to develop and share best practices in PRO collection and use across adult rheumatology practices in the United States
The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C-Reactive Protein Levels
Hoi Ki Joshua Tam,Peter Nash,Philip C. Robinson
doi : 10.1002/acr2.11312
Volume 3, Issue 10 p. 699-706
Biological agents have shown markedly different response rates by baseline C-reactive protein (CRP). Here, we determine the response of patients with nonradiographic axial spondyloarthritis (nr-axSpA) to etanercept stratified by their baseline CRP level.
Clinical Image: Splinter hemorrhage as a diagnostic clue of muscular polyarteritis nodosa
Mitsuharu Yoshida,Yoshinori Taniguchi
doi : 10.1002/acr2.11313
Volume 3, Issue 10 p. 707-707
Factors Associated With Variation in Pediatric Systemic Lupus Erythematosus Care Delivery
Jon M. Burnham,Lynsey Cecere,Joy Ukaigwe,Andrea Knight,Rosemary Peterson,Joyce C. Chang
doi : 10.1002/acr2.11314
Volume 3, Issue 10 p. 708-714
Patients with pediatric systemic lupus erythematosus (pSLE) and mixed connective tissue disease (MCTD) receive only a fraction of recommended care. Using published quality indicators and guidelines, we developed a 13-item pediatric lupus care index (p-LuCI) to quantify the proportion of recommended clinical evaluations and comorbidity prevention interventions completed and the timeliness of follow-up. Our objective was to assess baseline index performance and identify sources of p-LuCI variation.
Identifying Content Themes in Primary Care Physician and Rheumatologist Communications Within Electronic Consultations: A Qualitative Study
Jeanie Lee,Sharon Rikin,Ruchi Jain
doi : 10.1002/acr2.11317
Volume 3, Issue 10 p. 715-722
Electronic consultation (eConsult) communications between primary care physicians (PCPs) and rheumatologists may reveal common knowledge gaps and educational opportunities. The aim of our study was to identify content themes in PCP questions and rheumatology recommendations through analysis of eConsult and the need for rheumatology appointments and facilitated urgent visits post-eConsult.
High-Intensity Interval Training for Knee Osteoarthritis: A Pilot Study
Yvonne M. Golightly,Abbie E. Smith-Ryan,Malia N.M. Blue,Carolina Alvarez,Kelli D. Allen,Amanda E. Nelson
doi : 10.1002/acr2.11318
Volume 3, Issue 10 p. 723-732
To assess the feasibility and changes in outcomes of a 12-week high-intensity interval training (HIIT) program in individuals with symptomatic knee osteoarthritis (OA).
Adherence to Weight-Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Systemic Lupus Erythematosus and Rheumatoid Arthritis: Results of a Quality Improvement Initiative
Tara Skorupa,Robert H. Shmerling
doi : 10.1002/acr2.11320
Volume 3, Issue 10 p. 733-737
Hydroxychloroquine (HCQ) is commonly prescribed for the treatment of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other rheumatic diseases. To limit retinal toxicity, the 2016 American Academy of Ophthalmology (AAO) guidelines recommended limiting the HCQ dose to 5 mg/kg/day or less. Our objective was to develop a quality improvement program to improve adherence to these guidelines.
Clinical Images: Takayasu arteritis presenting with isolated pulmonary artery involvement and pericarditis treated with bypass and tocilizumab
Umaima Dhamrah,Ioannis Tassiulas,Olivia Ghaw,Emilie S. Chan
doi : 10.1002/acr2.11322
Volume 3, Issue 10 p. 738-738
